Bellevue Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,100
| Closed | -$334K | – | 177 |
|
|
2024
Q1 | $334K | Sell |
19,100
-10,900
| -36% | -$191K | 0.01% | 144 |
|
|
2023
Q4 | $653K | Sell |
30,000
-33,770
| -53% | -$736K | 0.01% | 129 |
|
|
2023
Q3 | $978K | Buy |
63,770
+19,370
| +44% | +$297K | 0.02% | 129 |
|
|
2023
Q2 | $1.06M | Sell |
44,400
-1,700
| -4% | -$40.4K | 0.02% | 129 |
|
|
2023
Q1 | $1.17M | Hold |
46,100
| – | – | 0.02% | 125 |
|
|
2022
Q4 | $1.35M | Hold |
46,100
| – | – | 0.02% | 133 |
|
|
2022
Q3 | $946K | Sell |
46,100
-2,900
| -6% | -$59.5K | 0.01% | 138 |
|
|
2022
Q2 | $567K | Buy |
+49,000
| New | +$567K | 0.01% | 147 |
|